Limb girdle muscular dystrophies: clinical-genetical diagnostic update and prospects for therapy

被引:5
|
作者
Angelini, Corrado [1 ]
Fanin, Marina [2 ]
机构
[1] San Camillo Hosp, Dept Neurodegenerat Disorders, Neuromuscular Ctr, IRCCS, Venice, Italy
[2] Univ Padua, Dept Neurosci, Padua, Italy
来源
EXPERT OPINION ON ORPHAN DRUGS | 2017年 / 5卷 / 10期
关键词
Limb girdle muscular dystrophy; LGMD; diagnosis; treatment; ONSET POMPE DISEASE; LAMIN A/C MUTATIONS; ALPHA-SARCOGLYCAN; BETA-SARCOGLYCAN; MUSCLE PATHOLOGY; MIYOSHI MYOPATHY; PHENOTYPIC VARIABILITY; ADENOASSOCIATED VIRUS; SEVERE CARDIOMYOPATHY; POTENTIAL BIOMARKERS;
D O I
10.1080/21678707.2017.1367283
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Limb Girdle Muscular Dystrophies (LGMD) are a clinically heterogeneous group of disorders presenting with a spectrum of disease severity ranging from severe childhood onset muscular dystrophy to adult-onset dystrophy. LGMDs include both dominant and recessive forms. Areas covered: The clinical phenotypes and diagnostic features of LGMD and specific features for each disease have been presented. An updated list of molecularly defined LGMD is provided. The instrumental, muscle imaging, and laboratory exams commonly used to assess final diagnosis are described, as well as recent genetic techniques and new diagnostic procedures, i.e. next generation sequencing, whole exome sequencing, RNA sequencing as compared to other techniques (e.g. protein analysis). The clinical management of patients and their main clinical respiratory and cardiac complications is covered. We also focus on current available future drugs or gene therapy and management by rehabilitation. Expert opinion: Many LGMD cases, who in the past remained for long time without a molecular diagnosis, nowadays can be investigated by next generation sequencing. Gene mutation analysis is always required to obtain a molecular diagnosis, and is fundamental to select patients for future pharmacological trials and gene therapies.
引用
收藏
页码:769 / 784
页数:16
相关论文
共 50 条
  • [1] The limb-girdle muscular dystrophies - Diagnostic strategies
    Bushby, Kate
    Norwood, Fiona
    Straub, Volker
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (02): : 238 - 242
  • [2] Diagnostic strategy for limb-girdle muscular dystrophies
    Eyrnard, B.
    Levy, N.
    REVUE NEUROLOGIQUE, 2012, 168 (12) : 919 - 926
  • [3] Limb Girdle Muscular Dystrophies
    Bockhorst, Jacob
    Wicklund, Matthew
    NEUROLOGIC CLINICS, 2020, 38 (03) : 493 - 504
  • [4] Limb girdle muscular dystrophies
    Finsterer, J
    NERVENARZT, 2004, 75 (12): : 1153 - +
  • [5] Limb girdle muscular dystrophies
    Mensova, L.
    Baumgartner, D.
    Potockova, V.
    Mazanec, R.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (06) : 435 - 448
  • [6] Ins and outs of therapy in limb girdle muscular dystrophies
    Daniele, Nathalie
    Richard, Isabelle
    Bartoli, Marc
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (09): : 1608 - 1624
  • [7] An update on diagnostic options and considerations in limb-girdle dystrophies
    Angelini, Corrado
    Giaretta, Laura
    Marozzo, Roberta
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (09) : 693 - 703
  • [8] Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches
    Nigro, Vincenzo
    Aurino, Stefania
    Piluso, Giulio
    CURRENT OPINION IN NEUROLOGY, 2011, 24 (05) : 429 - 436
  • [9] Limb-Girdle Muscular Dystrophies
    Angelini, C
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S4 - S4
  • [10] The Limb-Girdle Muscular Dystrophies
    Wicklund, Matthew P.
    Kissel, John T.
    NEUROLOGIC CLINICS, 2014, 32 (03) : 729 - +